Do you follow the GOLD standard for COPD diagnosis and management, mid-revenue cycle professionals?

By Brian Murphy

Are you following the GOLD standard for COPD diagnosis and management?

Medscape has a great article and video on this underreported diagnosis by Dr. Neil Skolnik. See link below. Here’s why I recommend it.

As always with articles of this sort I caveat that I’m not a clinician and I have a lapsed coding credential. Your interpretations may vary and I certainly welcome your input, disagreement, etc.

• COPD is hugely underdiagnosed, and therefore improved capture is almost certainly an opportunity for your organization. Per Medscape, 80% of people with COPD do not have that diagnosis made. “We should have a low threshold for testing for COPD,” Dr. Skolnik concludes.

• It offers clinical indicators for the CDI or coder. Per Medscape, if an older person has shortness of breath (either with exertion or rest), chronic cough, heavy sputum production or severe upper respiratory illnesses, think about possible COPD. Get that query going.

• It has what is needed for diagnosis (and therefore, coding). Confirm COPD with in-office spirometry or formal pulmonary function tests. Look for the presence of non-fully reversible airflow obstruction, which GOLD defines as an FEV1-to-FVC ratio of < 0.7 on postbronchodilator testing.

• It has what is needed for documentation support (and therefore, compliant billing). COPD is unfortunately irreversible, which is what makes it COPD … but not in the eyes of insurers. Recall that risk adjustment diagnoses “reset” each Jan. 1, and providers not only have to see the patient in a face-to-face encounter to report the diagnosis, but also meet a minimum documentation standard. Get that smoking assessment and CBC order in for MEAT.

• It arms you against denials. Payers love to grab and employ whatever criteria they can to deny a diagnosis. If you’re using some other standard they may use GOLD against you. This is an international standard and it seems to me should be your organizational standard as well. If payers aren’t using GOLD, you can back up yours with the “gold standard” (ahem).

• It has what is needed for ongoing treatment (and therefore, value for clinicians). Don’t just make it about documentation and coding; incorporate this into your CDI/coding education.

COPD has quality and payment ramifications. Since I also have a fresh copy 2026 ACDIS Pocket Guide let’s see what that says.

COPD with acute exacerbation codes to J44.1; COPD with acute lower respiratory infection codes to J44.0

Both are CCs. Both map to HCC 280 (relative weight 0.319) and also impact quality including readmission (HRRP) and 30-day mortality models. So capturing COPD with an exacerbation or associated infections is critical for direct and indirect reimbursement and quality scores.

References

• ACDIS, 2026 Pocket Guide
• Global Initiative for Chronic Obstructive Lung Disease.
• Medscape, New GOLD Standard for COPD Diagnosis and Management.